Healthcare provider profile · identity verified

Brian Christopher Glover, D.O.

Family Practice · MT STERLING, KY · NPI 1710205992

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	384	97
Levothyroxine Sodium	Levothyroxine Sodium	339	89
Amlodipine Besylate	Amlodipine Besylate	290	80
Omeprazole	Omeprazole	276	69
Losartan Potassium	Losartan Potassium	270	79
Lisinopril	Lisinopril	206	60
Famotidine	Famotidine	200	65
Montelukast Sodium	Montelukast Sodium	191	50
Metoprolol Succinate	Metoprolol Succinate	189	54
Gabapentin	Gabapentin	188	42
Pantoprazole Sodium	Pantoprazole Sodium	187	56
Metformin Hcl Er	Metformin Hcl	174	49
Carvedilol	Carvedilol	164	33
Rosuvastatin Calcium	Rosuvastatin Calcium	157	50
Clopidogrel	Clopidogrel Bisulfate	127	32
Tamsulosin Hcl	Tamsulosin Hcl	127	41
Ozempic	Semaglutide	111	20
Duloxetine Hcl	Duloxetine Hcl	108	28
Simvastatin	Simvastatin	108	27
Hydrochlorothiazide	Hydrochlorothiazide	103	40
Meloxicam	Meloxicam	102	29
Buspirone Hcl	Buspirone Hcl	99	26
Trazodone Hcl	Trazodone Hcl	99	22
Fluticasone Propionate	Fluticasone Propionate	98	40
Albuterol Sulfate Hfa	Albuterol Sulfate	96	27
Diclofenac Sodium	Diclofenac Sodium	95	41
Metformin Hcl	Metformin Hcl	94	28
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	93	21
Potassium Chloride	Potassium Chloride	90	31
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	87	69
Torsemide	Torsemide	87	18
Metoprolol Tartrate	Metoprolol Tartrate	78	22
Eliquis	Apixaban	76	19
Sertraline Hcl	Sertraline Hcl	76	16
Venlafaxine Hcl Er	Venlafaxine Hcl	74	15
Celecoxib	Celecoxib	71	29
Esomeprazole Magnesium	Esomeprazole Magnesium	71	23
Pravastatin Sodium	Pravastatin Sodium	71	19
Prednisone	Prednisone	67	43
Olmesartan Medoxomil	Olmesartan Medoxomil	61	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	59	16
Hydralazine Hcl	Hydralazine Hcl	58	16
Memantine Hcl	Memantine Hcl	58	21
Tramadol Hcl	Tramadol Hcl	58	17
Azithromycin	Azithromycin	56	45
Furosemide	Furosemide	56	22
Pregabalin	Pregabalin	56	12
Zolpidem Tartrate	Zolpidem Tartrate	56	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	55	suppressed
Valsartan	Valsartan	54	suppressed
Ezetimibe	Ezetimibe	53	13
Glipizide	Glipizide	53	13
Allopurinol	Allopurinol	52	16
Atenolol	Atenolol	52	14
Donepezil Hcl	Donepezil Hcl	51	13
Januvia	Sitagliptin Phosphate	51	14
Methylprednisolone	Methylprednisolone	50	48
Pioglitazone Hcl	Pioglitazone Hcl	50	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	15
Alendronate Sodium	Alendronate Sodium	47	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	13
Paroxetine Hcl	Paroxetine Hcl	47	suppressed
Lovastatin	Lovastatin	45	14
Propranolol Hcl	Propranolol Hcl	45	12
Trulicity	Dulaglutide	45	suppressed
Myrbetriq	Mirabegron	42	13
Bupropion Xl	Bupropion Hcl	41	12
Citalopram Hbr	Citalopram Hydrobromide	41	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	15
Doxazosin Mesylate	Doxazosin Mesylate	40	11
Lansoprazole	Lansoprazole	40	16
Lorazepam	Lorazepam	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	11
Glipizide Er	Glipizide	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Glimepiride	Glimepiride	38	11
Irbesartan	Irbesartan	38	11
Megestrol Acetate	Megestrol Acetate	38	suppressed
Spironolactone	Spironolactone	38	13
Ondansetron Odt	Ondansetron	36	12
Escitalopram Oxalate	Escitalopram Oxalate	35	11
Farxiga	Dapagliflozin Propanediol	34	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	12
Alprazolam	Alprazolam	32	suppressed
Cilostazol	Cilostazol	32	suppressed
Fluconazole	Fluconazole	31	18
Mounjaro	Tirzepatide	31	suppressed
Risperidone	Risperidone	31	suppressed
Amoxicillin	Amoxicillin	30	25
Ibu	Ibuprofen	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Primidone	Primidone	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	12
Jardiance	Empagliflozin	29	suppressed
Topiramate	Topiramate	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	20
Xarelto	Rivaroxaban	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	21
Doxycycline Monohydrate	Doxycycline Monohydrate	28	27
Finasteride	Finasteride	28	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Diazepam	Diazepam	27	suppressed
Linzess	Linaclotide	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Fenofibrate	Fenofibrate,micronized	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	18
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	11
Estradiol	Estradiol	22	suppressed
Amiloride Hcl	Amiloride Hcl	21	suppressed
Bumetanide	Bumetanide	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Cefdinir	Cefdinir	18	16
Nabumetone	Nabumetone	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Indomethacin	Indomethacin	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Sulfasalazine	Sulfasalazine	16	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Lactulose	Lactulose	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Levofloxacin	Levofloxacin	13	13
Mirtazapine	Mirtazapine	13	suppressed
Nystatin	Nystatin	13	12
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Vraylar	Cariprazine Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Livalo	Pitavastatin Calcium	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Temazepam	Temazepam	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Naratriptan Hcl	Naratriptan Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error